1. Home
  2. RDHL vs PW Comparison

RDHL vs PW Comparison

Compare RDHL & PW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • PW
  • Stock Information
  • Founded
  • RDHL 2009
  • PW 1967
  • Country
  • RDHL Israel
  • PW United States
  • Employees
  • RDHL N/A
  • PW N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • PW Real Estate Investment Trusts
  • Sector
  • RDHL Health Care
  • PW Real Estate
  • Exchange
  • RDHL Nasdaq
  • PW Nasdaq
  • Market Cap
  • RDHL 3.9M
  • PW 3.3M
  • IPO Year
  • RDHL N/A
  • PW N/A
  • Fundamental
  • Price
  • RDHL $1.70
  • PW $1.03
  • Analyst Decision
  • RDHL
  • PW
  • Analyst Count
  • RDHL 0
  • PW 0
  • Target Price
  • RDHL N/A
  • PW N/A
  • AVG Volume (30 Days)
  • RDHL 43.1K
  • PW 291.4K
  • Earning Date
  • RDHL 09-05-2025
  • PW 10-30-2025
  • Dividend Yield
  • RDHL N/A
  • PW N/A
  • EPS Growth
  • RDHL N/A
  • PW N/A
  • EPS
  • RDHL N/A
  • PW N/A
  • Revenue
  • RDHL $9,550,000.00
  • PW $2,988,491.00
  • Revenue This Year
  • RDHL $381.91
  • PW N/A
  • Revenue Next Year
  • RDHL N/A
  • PW N/A
  • P/E Ratio
  • RDHL N/A
  • PW N/A
  • Revenue Growth
  • RDHL 157.62
  • PW 45.51
  • 52 Week Low
  • RDHL $1.06
  • PW $0.63
  • 52 Week High
  • RDHL $11.70
  • PW $2.75
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 63.39
  • PW 43.00
  • Support Level
  • RDHL $1.47
  • PW $0.99
  • Resistance Level
  • RDHL $1.60
  • PW $1.09
  • Average True Range (ATR)
  • RDHL 0.09
  • PW 0.18
  • MACD
  • RDHL 0.04
  • PW -0.01
  • Stochastic Oscillator
  • RDHL 97.98
  • PW 18.42

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About PW Power REIT (MD)

Power REIT is an internally managed real estate investment trust (REIT) that owns a portfolio of real estate assets related to transportation, energy infrastructure, and Controlled Environment Agriculture (CEA) in the United States. Its investment portfolio comprises solar farm lands, railroad real estate, and various Controlled Environment Agriculture properties in the form of greenhouses for the cultivation of food and cannabis. In addition, the company is focused on opportunities in the form of investing in distressed situations, including debt and other types of secured interests in real estate, distressed properties, and real estate-related companies.

Share on Social Networks: